| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3941922 | Fertility and Sterility | 2008 | 5 Pages |
Abstract
Following on the heels of the discovery that endometriosis is an epigenetic disease, we conducted a pilot study on the off-label use of valproic acid to treat adenomyosis. We found that by the end of the 3-month treatment, all three recruited patients reported complete disappearance of dysmenorrhea, with an average of one-third reduction in uterus size.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Xishi Liu, Sun-Wei Guo,